RNXT
RenovoRx, Inc. · Healthcare · Market cap $55.5M
Insider Buying
$84K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
4
in the rolling window
Latest filing
Sep 15, 2026
VOLL MARK
RenovoRx, Inc. (RNXT) has 16 SEC Form 4 filings (20 transaction rows) in the rolling window, disclosed by 4 distinct insiders. Most recent filing: Sep 15, 2026.
Inside the rolling window, 4 insiders at RenovoRx, Inc. reported 13 open-market purchases totaling $84K and no open-market sales. The most active filer is Chief Medical Officer Agah Ramtin with 7 filings. The most recent open-market filing is a purchase of 25,000 shares by Chief Financial Officer VOLL MARK, dated May 19, 2026, worth $20K.
- Industry:Biotechnology
- CEO:Shaun R. Bagai
- Employees:17
- HQ:Mountain View, CA, US
- IPO:2021-08-26
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Financial Officer | Purchase | 25,000 | $20K | May 21 | +39.5% | SEC ↗ | |
VOLL MARKFirst filing | Chief Financial Officer | Purchase | 97,200 | — | Mar 24 | +13.9% | SEC ↗ |
Marton LaurenceFirst filing | Director | Purchase | 9,720 | — | Mar 24 | +13.9% | SEC ↗ |
Bagai ShaunFirst in 3 months | Chief Executive Officer | Purchase | 24,300 | — | Mar 24 | +13.9% | SEC ↗ |
| Chief Medical Officer | Purchase | 10,000 | $10K | Jan 22 | +20.6% | SEC ↗ | |
| Chief Medical Officer | Purchase | 9,795 | $8K | Jan 5 | +29.5% | SEC ↗ | |
| Chief Medical Officer | Purchase | 205 | $169 | Jan 2 | +47.3% | SEC ↗ | |
| Chief Executive Officer | Purchase | 5,000 | $5K | Dec 22 | +36.7% | SEC ↗ | |
Bagai ShaunFirst filing | Chief Executive Officer | Purchase | 5,000 | $4K | Dec 19 | +32.3% | SEC ↗ |
| Chief Medical Officer | Purchase | 12,000 | $10K | Dec 17 | +41.4% | SEC ↗ | |
| Chief Medical Officer | Purchase | 10,000 | $10K | Dec 8 | — | SEC ↗ | |
Agah RamtinFirst filing | Chief Medical Officer | Purchase | 10,000 | $8K | Nov 24 | — | SEC ↗ |
Agah RamtinFirst filing | Chief Medical Officer | Purchase | 12,000 | $10K | Nov 24 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does RNXT have?
RenovoRx, Inc. (RNXT) has 16 SEC Form 4 filings (20 transaction rows) in the rolling 365-day window, disclosed by 4 distinct insiders. Most recent filing: Sep 15, 2026.
When was the most recent SEC Form 4 filing for RNXT?
The most recent Form 4 filing for RNXT on Tracefour is dated Sep 15, 2026.
Who is the most active insider at RNXT?
The most active SEC Form 4 filer at RNXT in the rolling window is Chief Medical Officer Agah Ramtin, with 7 filings.
What is the net insider flow at RNXT over the last 6 months?
Over the trailing 180 days, insiders at RNXT have net bought $20K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at RNXT in the current window?
Inside the rolling window, insiders at RNXT bought $84K and sold $0 based on SEC Form 4 filings.
Can I get alerts for RNXT insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at RenovoRx, Inc. (RNXT). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
RenovoRx, Inc. is in the Healthcare sector.